Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2025-06-18 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 87% confidence The document is a stock exchange announcement notifying stakeholders of the appointment of a new non-executive director, detailing his background, tenure, and compliance with listing rules. This clearly falls under Board/Management Information rather than an annual or interim report, earnings release, or other category.
2025-06-18 English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE THIRD TRANCHE OF 2025 CORPORATE BONDS IN THE PRC
Capital/Financing Update Classification · 95% confidence The document is a stock exchange announcement regarding the successful issuance of the third tranche of 2025 corporate bonds by China Resources Pharmaceutical Group. It provides details on the principal amount, term, coupon rate, and intended use of proceeds. This constitutes a financing update rather than an earnings release, board change, or equity issuance. Therefore, it fits the “Capital/Financing Update” category.
2025-06-17 English
DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount Classification · 85% confidence The document is a Dividend Currency Election Form for shareholders to elect the currency (RMB or HKD) in which to receive the 2024 Final Dividend. It details the dividend amount, record date, election options, and submission instructions, and is clearly a dividend-related notice to shareholders. This fits the definition of a Notice of Dividend Amount (Code: DIV).
2025-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings Classification · 85% confidence The document is a monthly securities movements return (Form FF301) filed with HKEX under Listing Rule Chapter 19B, detailing movements in issued shares, treasury shares, and share options. It is a standing regulatory filing and does not announce a specific transaction like a buyback or share issue, nor is it an earnings or annual report. It does not fit any narrowly defined category (e.g., POS, SHA, IR). Therefore it falls under the fallback “Regulatory Filings” category (RNS).
2025-06-02 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 85% confidence The document is a corporate disclosure listing the company’s board members, their specific director roles (executive, non-executive, independent), and their membership/chairmanship of various board committees. There is no discussion of financial results, dividend notices, share transactions, legal matters, or calls/presentations. It is not announcing changes or appointments (so it is not MANG) but rather detailing the board structure and governance committee composition, fitting the Governance Information category.
2025-05-23 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 23 MAY 2025 AND CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND COMPOSITION OF BOARD COMMITTEES
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the Annual General Meeting held on 23 May 2025, detailing vote counts for each resolution (including dividend declaration, director re-elections, auditor appointment, share buy-back and issuance mandates) and follows with board changes (retirement and appointment of independent non-executive directors and committee compositions). This is precisely a declaration of voting results at an AGM. Accordingly, it falls under "Declaration of Voting Results & Voting Rights Announcements" (Code: DVA).
2025-05-23 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.